Design and rationale for the minimizing adverse haemorrhagic events by transradial access site and systemic implementation of angioX program

American Heart Journal

Volumn 168, Issue 6, 2014, Pages 838-845.e6

  Valgimigli, Marco ^a   Gagnor, Andrea ^c   Calabrò, Paolo ^d   Rubartelli, Paolo ^e   Garducci, Stefano ^f   Andò, Giuseppe ^g   Santarelli, Andrea ^h   Galli, Mario ⁱ   Garbo, Roberto ^j   Bramucci, Ezio ^k   Ierna, Salvatore ^l   Briguori, Carlo ^m   Cortese, Bernardo ⁿ   Limbruno, Ugo ^o   Violini, Roberto ^p   Presbitero, Patrizia ^q   De Cesare, Nicoletta ^r   Sganzerla, Paolo ^s   Ausiello, Arturo ^t   Tosi, Paolo ^u   Sardella, Gennaro ^v   Sabate’, Manel ^w   Brugaletta, Salvatore ^w   Saccone, Giovanni ^x   Vandoni, Pietro ^y   Zingarelli, Antonio ^z   Liso, Armando ^aa   Rigattieri, Stefano ^ab   Di Lorenzo, Emilio ^ac   Vigna, Carlo ^ad   Palmieri, Cataldo ^ae   Falcone, Camillo ^af   De Caterina, Raffaele ^ag   Caputo, Marcello ^ag   Esposito, Giovanni ^ah   Lupi, Alessandro ^ai   Mazzarotto, Pietro ^aj   Varbella, Fernando ^c   Zaro, Tiziana ^f   Nazzaro, Marco ^ak   Rao, Sunil V ^al   Van‘T Hof, Arnoud W J ^am   Omerovic, Elmir ^an   Uguccioni, Lucia ^ao   Tamburino, Corrado ^ap   Ferrari, Fabio ^aq   Ceravolo, Roberto ^ar   Tarantino, Fabio ^as   Casu, Gavino ^at   Cremonesi, Alberto ^au   Saia, Francesco ^av   Guiducci, Vincenzo ^aw   Dellavalle, Antonio ^ax   Curello, Salvatore ^ay   Mangiacapra, Fabio ^az   Evola, Rosario ^ba   Liistro, Francesco ^bb   Creaco, Manuela ^bc   Colombo, Antonio ^bd   Perkan, Andrea ^be   De Servi, Stefano ^bf   Fischetti, Dionigi ^bg   Pucci, Edoardo ^bh   Romagnoli, Enrico ^bi   Moretti, Claudio ^bj   Moretti, Luciano ^bk   Turturo, Maurizio ^bl   Bonmassari, Roberto ^bm   Penzo, Carlo ^bn   Loi, Bruno ^bo   Mauro, Ciro ^bp   Gabrielli, Gabriele ^bq   Micari, Antonio ^br   Petronio, Anna Sonia ^bs   Comeglio, Marco ^bt   Fresco, Claudio ^bu   Pasquetto, Giampaolo ^bv   Belloni, Flavia ^bw   Amico, Francesco ^bx   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Ospedale degli Infermi ^*  (Netherlands)

^c OSPEDALE DEGLI INFERMI   (Italy)

^d Hospital Dei Colli   (Italy)

^e VILLA SCASSI HOSPITAL   (Italy)

^f AO Ospedale civile di Vimercate (Monza e Brianza)   (Italy)

^g AO Universitaria G Martino   (Italy)

^h Azianda USL Rimini   (Italy)

ⁱ SANT ANNA HOSPITAL   (Italy)

^j MOLINETTE HOSPITAL   (Italy)

^k FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^l Div di Ostetricia e Ginecologia   (Italy)

^m Clinica Mediterranea   (Italy)

ⁿ Ospedale Fate Bene Fratelli   (Italy)

^o MISERICORDIA HOSPITAL   (Italy)

^p Azienda San Camillo Forlanini   (Italy)

^q HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^r Policlinico San Marco   (Italy)

^s AO Treviglio   (Italy)

^t Casa di Cura Villa Verde   (Italy)

^u Ospedale Mater Salutis di Legnago   (Italy)

^v Policlinico Umberto I   (Italy)

^w HOSPITAL CLÍNIC   (Spain)

^x AO Giovanni Paolo II   (Italy)

^y AO Ospedale di Desio   (Italy)

^z UNIVERSITY OF GENOA   (Italy)

^aa Citta di Lecce Hospital   (Italy)

^ab PO Sandro Pertini   (Italy)

^ac S G MOSCATI HOSPITAL   (Italy)

^ad CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^ae G PASQUINUCCI HOSPITAL   (Italy)

^af Ospedale Sacra Famiglia Fatebenefratelli   (Italy)

^ag UO Patologia Medica   (Italy)

^ah FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^ai Cardiochirurgia   (Italy)

^aj Ospedale di Lodi   (Italy)

^ak Stroke Unit   (Italy)

^al DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^am ISALA HOSPITAL   (Netherlands)

^an SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^ao A O Ospedali Riuniti   (Italy)

^ap AO Universitaria   (Italy)

^aq SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

^ar PUGLIESE CIACCIO HOSPITAL   (Italy)

^as MORGAGNI PIERANTONI HOSPITAL   (Italy)

^at SAN FRANCESCO HOSPITAL   (Italy)

^au MARIA CECILIA HOSPITAL   (Italy)

^av UNIVERSITY OF BOLOGNA   (Italy)

^aw S MARIA NUOVA HOSPITAL   (Italy)

^ax ASL 17   (Italy)

^ay SPEDALI CIVILI   (Italy)

^az UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^ba PO San Vincenzo   (Italy)

^bb IRCCS POLICLINICO SAN DONATO   (Italy)

^bc Ospedale Gravina   (Italy)

^bd SAN RAFFAELE HOSPITAL   (Italy)

^be UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^bf Ospedale Civile di Legnano   (Italy)

^bg VITO FAZZI HOSPITAL   (Italy)

^bh SANTA MARIA GORETTI HOSPITAL   (Italy)

^bi Casilino Clinic   (Italy)

^bj AOU San Giovanni Battista Molinette   (Italy)

^bk Psychiatric Service of Diagnosis and Treatment   (Italy)

^bl DI VENERE HOSPITAL   (Italy)

^bm SANTA CHIARA HOSPITAL   (Italy)

^bn Ospedale Civile di Mirano   (Italy)

^bo BROTZU HOSPITAL   (Italy)

^bp CARDARELLI HOSPITAL   (Italy)

^bq Ospedali Riuniti di Ancona   (Italy)

^br Villa Maria Eleonora Hospital   (Italy)

^bs CISANELLO HOSPITAL   (Italy)

^bt Ospedale del Ceppo   (Italy)

^bu SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^bv P O di Este   (Italy)

^bw SPIRITO SANTO HOSPITAL   (Italy)

^bx Neurology Unit   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTITHROMBIN; CLOPIDOGREL; FONDAPARINUX; HEPARIN; HIRULOG; PRASUGREL; TICAGRELOR; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DRUG ADMINISTRATION ROUTE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MALE; MIDDLE AGED; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; TRANSFEMORAL ACCESS; TRANSRADIAL ACCESS; TREATMENT DURATION; AGED; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; EUROPE; FEMORAL ARTERY; MORTALITY; MYOCARDIAL INFARCTION; POSTOPERATIVE HEMORRHAGE; RADIAL ARTERY; STROKE; SURVIVAL; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ANTITHROMBINS; EUROPE; FEMALE; FEMORAL ARTERY; HEPARIN; HIRUDINS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POSTOPERATIVE HEMORRHAGE; RADIAL ARTERY; RECOMBINANT PROTEINS; STROKE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84912122869     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.08.013     Document Type: Article

References (20)

1. Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2012;126: 875-910.
2. Steg PG, James SK, Atar D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619.
3. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358: 2218-30.
4. Majure DT, Aberegg SK. Fondaparinux versus enoxaparin in acute coronary syndromes. N Engl J Med 2006;354:2829. [author reply 2830].
5. Vranckx P, Campo G, Anselmi M, et al. Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction. EuroIntervention 2012;8:71-8.
6. Valgimigli M, Saia F, Guastaroba P, et al. Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and-matched analysis from the REAL (REgistro regionale AngiopLastiche dell'Emilia-Romagna) multicenter registry. J Am Chem Soc 2012;5:23-35.
7. Jolly SS, Yusuf S, Cairns J, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 2011;377:1409-20.
8. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol 2012;60:2481-9.
9. Lee MS, Wolfe M, Stone GW. Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: reevaluation of the current body of evidence. J Am Chem Soc 2013;6: 1149-52.
10. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006;355:2203-16.
11. Lincoff AM, Bittl JA, Kleiman NS, et al. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). Am J Cardiol 2004;93:1092-6.
12. Steg PG, van 't Hof A, Hamm CW, et al. Bivalirudin started during emergency transport for primary PCI. N Engl J Med 2013;369: 2207-17.
13. Bernat I, Horak D, Stasek J, et al. ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial. J Am Coll Cardiol 2014;63:964-72.
14. Valgimigli M, Calabro P, Cortese B, et al. Scientific foundation and possible implications for practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX (MATRIX) trial. J Cardiovasc Transl Res 2014;7:101-11.
15. Parodi G, Antoniucci D, Nikolsky E, et al. Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. J Am Chem Soc 2010;3:796-802.
16. Yusuf S, Mehta SR, Chrolavicius S, et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006;354:1464-76.
17. Steg PG, van 't Hof A, Hamm CW, et al. Bivalirudin started during emergency transport for primary PCI. N Engl J Med 2013;369(23): 2207-17.
18. Shahzad A, Kemp I, Mars C, et al. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEATPPCI): an open-label, single centre, randomised controlled trial. Lancet 2014 http://dx.doi.org/10.1016/S0140-6736(14)60924-7. [pii: S0140-6736(14)].
19. Cannon CP, Harrington RA, James S, et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet 2010;375:283-93.
20. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15.